Lack of Benefit of High Flow Nasal Oxygen Therapy as Ceiling of Treatment for Severe COVID-19 Pneumonitis in Elderly Frail Patients: A Single Centre Observational Study.

Fatema MerchantAkash MavilakandyHarvinder S VirkSajid KhanGeorgios TsaknisMuhammad NaeemSrikumar MallikKirsty DatsonRaja Reddy

Published in: The open respiratory medicine journal (2022)

Elderly frail patients with severe COVID-19 pneumonitis deemed inappropriate for invasive ventilation and did not benefit from HFNO. Further, HFNO may have been associated with harm in this group.

Keyphrases

community dwelling
coronavirus disease
sars cov
end stage renal disease
ejection fraction
early onset
newly diagnosed
interstitial lung disease
prognostic factors
rheumatoid arthritis
systemic sclerosis
mesenchymal stem cells
replacement therapy